| Bioactivity | SARS-CoV-2-IN-95 (Compound 10) is an inhibitor for SARS-CoV-2 PLpro with an IC50 of 0.39 μM. SARS-CoV-2-IN-95 exhibits antiviral activity in mouse SARS-CoV-2-infected model[1]. |
| Target | IC50: 0.39 μM (SARS-CoV-2 PLpro) |
| CAS | 2817810-96-9 |
| Formula | C29H36N4OS |
| Molar Mass | 488.69 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Velma GR, et al., Non-Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease (PLpro): In Vitro and In Vivo Antiviral Activity. J Med Chem. 2024 Aug 5. |
SARS-CoV-2-IN-95
CAS: 2817810-96-9 F: C29H36N4OS W: 488.69
SARS-CoV-2-IN-95 (Compound 10) is an inhibitor for SARS-CoV-2 PLpro with an IC50 of 0.39 μM. SARS-CoV-2-IN-95 exhibits
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.